Hans-Christian K.
- Country
- Germany
- Department
- Klinik für Gynäkologie, Geburtshilfe, Senologie und gynäkologische Onkologie
Research Overview
- Evaluation of Safety and Efficacy of Elacestrant in Combination Therapies for Patients with Metastatic Breast Cancer: A Phase 1b/2 Open-Label Umbrella Study
- Comparison of Adjuvant Elacestrant with Standard Endocrine Therapy in High-Risk ER+/HER2- Early Breast Cancer
- Study of Inavolisib with Trastuzumab and Pertuzumab as Maintenance Therapy in Patients with HER2‑Positive PIK3CA‑Mutated Locally Advanced or Metastatic Breast Cancer
Data & Insights
Has run more than one trial at 419 of 802 partner sites.
Specializations
Early Stage Breast Cancer
Specializes in research involving hormone receptor-positive (HR+) and HER2-positive early breast cancer treatments. Focus on innovative therapeutic approaches for patients with high risk of recurrence.
- Adjuvant therapy optimization
- Targeted molecular treatments
- Neoadjuvant therapeutic strategies
Particular interest in personalized treatment approaches for early-stage breast cancer patients with specific genetic markers.
Advanced Breast Cancer
Conducts research in metastatic breast cancer treatment, with emphasis on novel therapeutic combinations and targeted approaches for different breast cancer subtypes.
- Triple-negative breast cancer therapy
- HER2-low treatment strategies
- Hormone receptor-positive advanced disease
Focuses on developing treatment strategies for patients with locally advanced or metastatic disease.
Precision Medicine Applications
Investigates biomarker-driven treatments and targeted therapies for specific breast cancer molecular subtypes.
- BRCA mutation targeted treatments
- Endocrine therapy resistance
- Immunotherapy combinations
Specialized focus on molecular profiling and personalized treatment approaches in breast cancer.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.